Skip to main navigation
Skip notifications
Access to POEMs and Essential Evidence Plus will no longer be included in CMA membership as of Dec. 1, 2023.
Search
Postexposure prophylaxis with doxycycline reduces STIs in men having sex with men
Clinical Question
Can postexposure prophylaxis with doxycycline reduce the risk of sexually transmitted infections in men who have sex with men?
Bottom line
In high-risk men who have sex with men, postexposure prophylaxis (PEP) with doxycycline reduces the risk of new sexually transmitted infections (STIs), including chlamydia and syphilis. No benefit occurred in reducing the risk of gonorrhea infection. 1b
Reference
Study design: Randomized controlled trial (nonblinded)
Funding: Government
Setting: Outpatient (any)
Synopsis
Higher rates of STIs are being reported among individuals using pre-exposure prophylaxis (PrEP) against HIV acquisition, most likely due to reduced condom use, These investigators initiated an open-label study extension of the ANRS IPERGAY trial, which showed the efficacy of PrEP in reducing HIV incidence. Eligible participants—232 HIV-negative men or transgendered women having sex with men—randomly received (concealed allocation assignment) either doxycycline PEP or no prophylaxis in addition to PrEP. Patients in the PEP group were instructed to take doxycycline (200 mg) after each high-risk sexual intercourse event (ie, condomless anal or oral sex) within 24 to 72 hours, but no more than 600 mg total per week. Participants underwent standard testing for STIs at baseline and every 2 months for a median of 8.7 months. Individuals who assessed outcomes remained masked to treatment group assignment. Complete follow-up occurred for 91% of participants. Using intention-to-treat analysis, significantly fewer STIs occurred in the PEP group than in the control group (22% vs 42%; number needed to treat = 6.8; 95% CI 3.8 - 37.0). In subgroup analyses, the occurrences of chlamydia and syphilis infections were significantly lower with PEP than without, but there was no significant group difference in the occurrence of gonorrhea infections.
Reviewer
David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC
Comments
Dans une population plus à risqueclest certainement rassurant qu’une simple dose de doxycycline permet de faire la différence en plus de donner la PrEP
good poem
Interesting and retro idea: there was a time before AIDS when gay guys and other sexually actively groups were prophylactically self-treating for STIs. In light of our current lens on antimicrobial stewardship, I wish the author had addressed issues of resistance. Will raise this paper with our Infectious Disease colleagues when we meet next month.
Note to editor/author: correct use is “transgender women” rather than “transgendered women”.
Interesting but I'd wait for Public Health guidelines before implementing.